Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06309979 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess Growth in Children With Idiopathic Short Stature

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 40 to 38v7
  2. Study sites: 19 to 40v6
  3. Enrollment target: 600 to 300
    • Study sites: 11 to 19
    • Eligibility criteria expanded, about 32 words
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Study sites: 5 to 11v3
  6. Start date changed from estimate of Mar 25, 2024 to Aug 8, 2024
    • Study sites: 1 to 5
    • Eligibility criteria expanded, about 10 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Trial Details
NCT Number NCT06309979
Lead Sponsor BioMarin Pharmaceutical
Conditions
(from sponsor)		 Idiopathic Short Stature
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov